Dyserythropoietic Anemia and Thrombocytopenia due to a Novel Mutation in GATA-1

Hematopoiesis is a complex process regulated by nuclear proteins that coordinate lineage-specific patterns of gene expression. Targeted mutagenesis has revealed critical roles for the X-linked transcription factor GATA-1 in erythrocyte and megakaryocyte differentiation. GATA-1 has two zinc fingers essential for normal function. The C-terminal finger is necessary for DNA binding. The N-terminal finger mediates interaction with FOG-1, a cofactor for GATA-1. Mutations in the N-terminal zinc finger of GATA-1 result in abnormal hematopoiesis. Here we report a family with a novel single base mutation that results in an amino acid substitution (Gly208Arg) within the highly conserved portion of the GATA-1 N-terminal finger domain, leading to dyserythropoietic anemia and macrothrombocytopenia. Another mutation described at the same codon (208) has been found to be associated with thrombocytopenia only. Our data support and extend the effect of the amino acid substitution at codon 208 on GATA-1 function not only regarding megakaryocyte but also regarding erythroid development.

[1]  Shih-Feng Tsai,et al.  Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells , 1989, Nature.

[2]  S. Orkin,et al.  A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development , 1997, The EMBO journal.

[3]  F. Fabris,et al.  Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. , 2003, Haematologica.

[4]  C Thys,et al.  Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. , 2001, Blood.

[5]  S. Orkin,et al.  Consequences of GATA-1 deficiency in megakaryocytes and platelets. , 1999, Blood.

[6]  S. Orkin,et al.  Embryonic stem cells and transgenic mice in the study of hematopoiesis. , 1998, The International journal of developmental biology.

[7]  J. Vermylen,et al.  Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. , 2002, Human molecular genetics.

[8]  G. Felsenfeld,et al.  The erythroid-specific transcription factor eryf1: A new finger protein , 1989, Cell.

[9]  J. Mackay,et al.  Key Residues Characteristic of GATA N-fingers Are Recognized By FOG* , 1998, The Journal of Biological Chemistry.

[10]  Y Fujiwara,et al.  Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Mackay,et al.  The solution structure of the N-terminal zinc finger of GATA-1 reveals a specific binding face for the transcriptional co-factor FOG , 1999, Journal of biomolecular NMR.

[12]  S. Orkin,et al.  X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. , 2002, Blood.

[13]  S. Orkin,et al.  Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1 , 2000, Nature Genetics.

[14]  S. Orkin,et al.  GATA transcription factors: key regulators of hematopoiesis. , 1995, Experimental hematology.

[15]  S. Orkin,et al.  Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. , 1998, Genes & development.

[16]  S. Orkin,et al.  Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. , 1999, Molecular cell.

[17]  M. Crossley,et al.  X-linked thrombocytopenia caused by a novel mutation of GATA-1. , 2001, Blood.

[18]  H. Yang,et al.  Distinct roles for the two cGATA-1 finger domains , 1992, Molecular and cellular biology.